Companies
Biotalys
the Dutch CTGB recommended EU-wide approval of the AGROBODY protein biofungicide EVOCA for Botrytis and powdery mildew, the first such recommendation for a protein-based biocontrol.
- Country
- Belgium
- Ticker
- Euronext:BTLS
EPA approved
Coverage
| CN | EU | US | |
|---|---|---|---|
| agri-inputs-biocontrol | ✓ | ✓ | ✓ |
Regulatorsepaefsamoa-china
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | €12.05 million private placement closed in May 2026 | biotalys.com |
| Regulatory approval | US EPA approval for EVOCA (December 2025); Florida state registration (April 2026) | biotalys.com |
| Regulatory approval | Dutch CTGB recommended EU-wide approval of EVOCA's active ingredient (as of February 2025) | biotalys.com · agribusinessglobal.com |
| Headcount | 62 employees as of March 2026 | marketscreener.com |
| Revenue | €3.043 million in other operating income for 2025 (no commercial product revenue yet) | biotalys.com |
Independent sources: agribusinessglobal.com · marketscreener.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Micropeptide plant-protection agents | agri-inputs-biocontrol | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.